Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karoline Rutter

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Liver Disease|April 18, 2019
HPS: Diagnosis, clinical features, and medical therapyValentin Fuhrmann, Andreas Drolz, Karoline Rutter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 2, 2012
Revisiting the predictors of a sustained virologic response in the era of direct-acting antiviral therapy for hepatitis C virusSandra Beinhardt, Karoline Rutter, Albert Friedrich Stättermayer, et al.
World Journal of Surgery|July 21, 2010
Hospitalization, frequency of interventions, and quality of life after endoscopic, surgical, or conservative treatment in patients with chronic pancreatitisKaroline Rutter, A Ferlitsch, T Sautner, et al.
Wiener Klinisches Magazin : Beilage Zur Wiener Klinischen Wochenschrift|April 15, 2020
[Acute liver failure]Karoline Rutter, Thomas Horvatits, Andreas Drolz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2016
Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosisThomas Horvatits, Andreas Drolz, Kevin Roedl, et al.
Annals of Intensive Care|December 6, 2015
Prognostic impact of ICG-PDR in patients with hypoxic hepatitisThomas Horvatits, Nikolaus Kneidinger, Andreas Drolz, et al.
Plos One|August 15, 2015
Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided TherapyRobert Strassl, Karoline Rutter, Albert Friedrich Stättermayer, et al.
Hepatology (Baltimore, Md.)|September 21, 2011
Treatment of chronic hepatitis C genotype 1 patients at an academic center in Europe involved in prospective, controlled trials: is there a selection bias?Sandra Beinhardt, Albert F Staettermayer, Karoline Rutter, et al.
Zeitschrift Fur Gastroenterologie|December 13, 2016
Serum bile acids in patients with hepatopulmonary syndromeThomas Horvatits, Andreas Drolz, Karoline Rutter, et al.
Gastroenterology|September 6, 2008
Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapyPeter Ferenci, Thomas-Matthias Scherzer, Heidrun Kerschner, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Liver Disease|April 18, 2019
HPS: Diagnosis, clinical features, and medical therapyValentin Fuhrmann, Andreas Drolz, Karoline Rutter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 2, 2012
Revisiting the predictors of a sustained virologic response in the era of direct-acting antiviral therapy for hepatitis C virusSandra Beinhardt, Karoline Rutter, Albert Friedrich Stättermayer, et al.
World Journal of Surgery|July 21, 2010
Hospitalization, frequency of interventions, and quality of life after endoscopic, surgical, or conservative treatment in patients with chronic pancreatitisKaroline Rutter, A Ferlitsch, T Sautner, et al.
Wiener Klinisches Magazin : Beilage Zur Wiener Klinischen Wochenschrift|April 15, 2020
[Acute liver failure]Karoline Rutter, Thomas Horvatits, Andreas Drolz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2016
Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosisThomas Horvatits, Andreas Drolz, Kevin Roedl, et al.
Annals of Intensive Care|December 6, 2015
Prognostic impact of ICG-PDR in patients with hypoxic hepatitisThomas Horvatits, Nikolaus Kneidinger, Andreas Drolz, et al.
Plos One|August 15, 2015
Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided TherapyRobert Strassl, Karoline Rutter, Albert Friedrich Stättermayer, et al.
Hepatology (Baltimore, Md.)|September 21, 2011
Treatment of chronic hepatitis C genotype 1 patients at an academic center in Europe involved in prospective, controlled trials: is there a selection bias?Sandra Beinhardt, Albert F Staettermayer, Karoline Rutter, et al.
Zeitschrift Fur Gastroenterologie|December 13, 2016
Serum bile acids in patients with hepatopulmonary syndromeThomas Horvatits, Andreas Drolz, Karoline Rutter, et al.
Gastroenterology|September 6, 2008
Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapyPeter Ferenci, Thomas-Matthias Scherzer, Heidrun Kerschner, et al.
Pageof 3